SciVision Biotech Inc. (1786.TW)
TWD 96.3
(-0.82%)
TWD 96.3
(-0.82%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.16 Billion TWD | 2.95% |
| 2022 | 2.09 Billion TWD | -7.24% |
| 2021 | 2.26 Billion TWD | 19.63% |
| 2020 | 1.89 Billion TWD | 1.55% |
| 2019 | 1.86 Billion TWD | 9.79% |
| 2018 | 1.69 Billion TWD | 8.48% |
| 2017 | 1.56 Billion TWD | 15.18% |
| 2016 | 1.35 Billion TWD | 26.51% |
| 2015 | 1.07 Billion TWD | -1.75% |
| 2014 | 1.09 Billion TWD | -3.29% |
| 2013 | 1.12 Billion TWD | 133.62% |
| 2012 | 483.28 Million TWD | 19.66% |
| 2011 | 403.87 Million TWD | 81.13% |
| 2010 | 222.97 Million TWD | 18.35% |
| 2009 | 188.4 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.25 Billion TWD | 4.24% |
| 2024 Q2 | 2.33 Billion TWD | 3.49% |
| 2023 Q4 | 2.16 Billion TWD | 0.6% |
| 2023 Q3 | 2.14 Billion TWD | -2.3% |
| 2023 FY | 2.16 Billion TWD | 2.95% |
| 2023 Q1 | 2.12 Billion TWD | 1.26% |
| 2023 Q2 | 2.19 Billion TWD | 3.45% |
| 2022 FY | 2.09 Billion TWD | -7.24% |
| 2022 Q4 | 2.09 Billion TWD | -11.41% |
| 2022 Q3 | 2.36 Billion TWD | 17.49% |
| 2022 Q2 | 2.01 Billion TWD | 2.0% |
| 2022 Q1 | 1.97 Billion TWD | -12.63% |
| 2021 FY | 2.26 Billion TWD | 19.63% |
| 2021 Q2 | 2.28 Billion TWD | 2.51% |
| 2021 Q4 | 2.26 Billion TWD | -0.95% |
| 2021 Q1 | 2.22 Billion TWD | 17.66% |
| 2021 Q3 | 2.28 Billion TWD | 0.14% |
| 2020 Q3 | 1.86 Billion TWD | -2.84% |
| 2020 FY | 1.89 Billion TWD | 1.55% |
| 2020 Q4 | 1.89 Billion TWD | 1.18% |
| 2020 Q1 | 1.88 Billion TWD | 1.39% |
| 2020 Q2 | 1.92 Billion TWD | 1.88% |
| 2019 Q4 | 1.86 Billion TWD | 3.43% |
| 2019 Q1 | 1.86 Billion TWD | 10.08% |
| 2019 FY | 1.86 Billion TWD | 9.79% |
| 2019 Q3 | 1.8 Billion TWD | -4.32% |
| 2019 Q2 | 1.88 Billion TWD | 0.78% |
| 2018 Q2 | 1.62 Billion TWD | 0.89% |
| 2018 Q1 | 1.6 Billion TWD | 2.78% |
| 2018 FY | 1.69 Billion TWD | 8.48% |
| 2018 Q4 | 1.69 Billion TWD | -0.84% |
| 2018 Q3 | 1.71 Billion TWD | 5.51% |
| 2017 Q1 | 1.34 Billion TWD | -0.69% |
| 2017 Q3 | 1.56 Billion TWD | 3.29% |
| 2017 Q4 | 1.56 Billion TWD | 0.19% |
| 2017 FY | 1.56 Billion TWD | 15.18% |
| 2017 Q2 | 1.51 Billion TWD | 12.07% |
| 2016 Q2 | 1.27 Billion TWD | 2.7% |
| 2016 Q1 | 1.24 Billion TWD | 16.06% |
| 2016 FY | 1.35 Billion TWD | 26.51% |
| 2016 Q3 | 1.31 Billion TWD | 3.14% |
| 2016 Q4 | 1.35 Billion TWD | 2.9% |
| 2015 Q4 | 1.07 Billion TWD | -1.79% |
| 2015 FY | 1.07 Billion TWD | -1.75% |
| 2015 Q3 | 1.09 Billion TWD | 1.78% |
| 2015 Q2 | 1.07 Billion TWD | -0.85% |
| 2015 Q1 | 1.08 Billion TWD | -0.87% |
| 2014 Q3 | 1.09 Billion TWD | -3.48% |
| 2014 Q2 | 1.13 Billion TWD | -0.11% |
| 2014 Q1 | 1.13 Billion TWD | 0.52% |
| 2014 FY | 1.09 Billion TWD | -3.29% |
| 2014 Q4 | 1.09 Billion TWD | -0.21% |
| 2013 Q4 | 1.12 Billion TWD | 119.52% |
| 2013 Q1 | 485.13 Million TWD | 0.38% |
| 2013 FY | 1.12 Billion TWD | 133.62% |
| 2013 Q3 | 514.32 Million TWD | 2.81% |
| 2013 Q2 | 500.28 Million TWD | 3.12% |
| 2012 FY | 483.28 Million TWD | 19.66% |
| 2012 Q3 | 451.73 Million TWD | 5.24% |
| 2012 Q2 | 429.24 Million TWD | 0.0% |
| 2012 Q4 | 483.28 Million TWD | 6.98% |
| 2011 Q4 | 403.87 Million TWD | 0.0% |
| 2011 Q2 | 372.34 Million TWD | 0.0% |
| 2011 FY | 403.87 Million TWD | 81.13% |
| 2010 Q4 | 222.97 Million TWD | 0.0% |
| 2010 FY | 222.97 Million TWD | 18.35% |
| 2009 FY | 188.4 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Nang Kuang Pharmaceutical Co., Ltd. | 3.85 Billion TWD | 43.981% |
| Maxigen Biotech Inc. | 1.49 Billion TWD | -44.688% |
| Bionime Corporation | 5.3 Billion TWD | 59.246% |
| Pegavision Corporation | 13.85 Billion TWD | 84.413% |
| Visco Vision Inc. | 4.72 Billion TWD | 54.272% |